The board / Oral semaglutide 25 mg vs Orforglipron
Oral division

Oral semaglutide 25 mg

AClass-leading
Novo Nordisk · approved
vs
Oral division

Orforglipron (Foundayo)

CompetitiveB
Eli Lilly · approved
11% · leads
Efficacy
9%
Clean (+1) · gentler
Tolerability
Notable (+7.6)
Oral pill
Route
Oral pill
Must take fasting: empty stomach, limited water, wait before eating
Food / water rule
None
Room temperature
Storage
Room temperature
The call: The oral matchup, and against the hype: oral semaglutide out-does orforglipron on both efficacy and tolerability, so it takes the class-leading grade. Orforglipron's real case is convenience: no fasting rule, no cold chain, and small-molecule manufacturing that scales. If you want the most loss from a pill, oral semaglutide; if access and living with it decide, orforglipron is the one you will actually keep taking.
Standalone, this page carries its own key: Efficacy = % body weight lost vs placebo, on the conservative estimand that counts everyone. Tolerability = AE-discontinuation over placebo (Mild 1 to 5 · Notable 5 to 10 · Heavy over 10 points). Winners are called only across a tier or band boundary; within one, the drugs are effectively tied. The side marked leads or gentler wins that axis.

Oral semaglutide 25 mg verdict · Orforglipron verdict · Is the pill as good as the shot? · How this is scored